|
ProCAID: A randomized double-blind phase II clinical trial of capivasertib (C) in combination with docetaxel and prednisolone chemotherapy (DP) in metastatic castration-resistant prostate cancer (mCRPC). |
|
|
Honoraria - Astellas Pharma; Bayer; Janssen-Cilag; MSD; Roche |
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Clovis Oncology; Janssen-Cilag; MSD; Roche |
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Plexxikon |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen-Cilag; Roche |
|
|
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst) |
Patents, Royalties, Other Intellectual Property - Patent on ASTEX drug working in new cancer area (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Abbvie |
Research Funding - Qiagen |
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Janssen-Cilag |
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Janssen Oncology; Roche; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Roche |
Speakers' Bureau - Pfizer |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Ipsen |
|
|
|
Consulting or Advisory Role - BMSi |
Travel, Accommodations, Expenses - BMSi; Novartis |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen; MSD Oncology; Novartis; Pfizer; Pharmacyclics; Roche/Genentech; Sanofi; Seagen |
Consulting or Advisory Role - Clovis Oncology |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; MSD |